BioControl Medical Crosses Important Enrollment Milestone in INOVATE-HF Study Evaluating CardioFit® System in Heart ...

BioControl Medical announced today that it has reached an important clinical trial milestone, reaching 480 randomized subjects – or 70 percent – of the planned 650 subjects with congestive heart failure in the INOVATE-HF trial of its CardioFit® system, the first medical device designed to treat HF using neurostimulation.



from Content Keyword RSS http://ift.tt/1B0lwWM

via IFTTT